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Terminal ileum hemosiderosis secondary to prolonged oral iron 
ingestion
Georgios Mavrogenisa, Julie Lelotteb, Anne Jouret-Mourinb, Kassem Azzouzia
Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium
A 74-year-old Asian woman was referred for outpatient 
upper and lower endoscopic screening. She had history of 
hyperlipidemia and vegetarianism. Her medications included 
atorvastatin and self-medication of oral iron for the last 10 years. 
Routine blood tests were normal. Esophagogastroduodenoscopy 
was macroscopically and histologically normal. Colonoscopy 
disclosed diffuse brownish tiny spots of the mucosa of the 
terminal ileum (Fig.  1). Biopsy specimens showed pigment 
deposition at the level of the lamina propria (Fig. 2). A positive 
iron stain indicated hemosiderin deposition. Retrospective 
review of the patient’s medical archives over the last 16 years 
revealed normal iron studies without any signs of iron deficiency 
anemia, hemolysis or hemochromatosis. She was consequently 
asked to discontinue iron supplements.
Hemosiderosis of the gastrointestinal tract is usually 
associated with hemochromatosis, chronic renal failure, 
diabetes, oral or parenteral iron therapy, multiple blood 
transfusions and several antihypertensive medications (primary 
hydralazine and furosemide). It has been described to affect the 
whole gastrointestinal tract, with the duodenum reported as the 
most common extracolonic site. A PubMed research revealed 
only 5  case reports of hemosiderosis isolated to the terminal 
ileum, associated with chronic oral iron intake (2 cases) and/or 
chronic renal failure (2 cases) or hemochromatosis (1 case) [1-3]. 
Gastroenterologists should be aware of this rare endoscopic 
entity and its association with long-term iron supplementation 
to avoid unnecessary further investigation.
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Figure 1 (A) Pigmented mucosa of the terminal ileum as seen by white 
light and (B) narrow-band imaging
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Figure 2 (A) Histology revealed brown pigment deposition within 
macrophages in lamina propria of normal villi (Hematoxylin-Eosin, 
40x) (B) Positive Prussian blue stain suggesting hemosiderosis (40x)
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